Transcript FAPMA Parliamentary Roundtable Presentation

Making Africa a competitor in the
Global Pharmaceutical Industry:
Federation of African
Pharmaceutical Manufacturers
Associations (FAPMA)
Dr Skhumbuzo Ngozwana
The Parliamentary Roundtable
Midrand, South Africa 25 – 26 March 2014
PMPA Vision
To develop a competitive and enduring
integrated pharmaceutical manufacturing
industry in Africa, able to respond to the
continent’s need for a secure and reliable
supply of quality, affordable, accessible,
safe and efficacious medicines.
2
African Pharma Value Chain
3
African Pharma growth drivers
4
Future disease burden
 60 million people with hypertension by 2020
 1 million cases of cancer annually
 18.6 million people with diabetes by 2020
 Other CVS, chronic respiratory diseases (COPD /
asthma) and neuro-psychiatric conditions
 NCD’s will have surpassed infectious diseases as the leading
cause of death in Africa by 2030.
Source: WHO, WHO AFRO, Frost & Sullivan analysis
Key PMPA Success Factors
6
There will be skeptics!
Lord Kelvin, President of the Royal Society 1890-1895
“Radio has no future”
“Heavier than air flying machines are
impossible”
“X-rays will prove to be a hoax”
There will be skeptics!
“No Indian company can
make an API that meets
our specifications”
Global R&D company in letter to Dr Reddys in 1984
8
“Pharma is amongst the best performing
sectors in Africa; the industry has been
growing at a steady rate over the past few
years and this momentum is expected to
continue in tandem with overall economic
growth being witnessed in Africa”
Ahmed Badreldin, Partner and Head of MENA at The Abraaj Group